Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human Semaphorin 4A Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB4694SP
This item is not returnable.
View return policy
Description
Semaphorin 4A Monoclonal specifically detects Semaphorin 4A in Human samples. It is validated for Flow Cytometry, CyTOF-ready.Specifications
Semaphorin 4A | |
Monoclonal | |
LYOPH | |
Flow Cytometry 2.5 ug/10^6 cells, CyTOF-ready | |
Q9H3S1 | |
SEMA4A | |
Mouse myeloma cell line NS0-derived recombinant human Semaphorin 4A Gly32-His683 Accession # Q9H3S1 | |
25 μg | |
Primary | |
Detects human Semaphorin 4A in direct ELISAs. In direct ELISAs, 50%-100% cross-reactivity with recombinant human (rh) Semaphorin 4C and rhSemaphorin 4G is observed, and less than 5% cross-reactivity with rhSemaphorin 4B, 4D, and recombinant mouse Semaphorin 4A is observed. | |
Human | |
Purified |
Flow Cytometry, CyTOF | |
741531 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
CORD10, RP35, Sema B, sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and shortcytoplasmic domain, (semaphorin) 4A, SEMA4A, SEMAB, semaphorin-4A, Semaphorin-B, SemB, SEMBFLJ12287 | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
64218 | |
Sterile PBS to a final concentration of 0.5 mg/mL. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction